Coronary Artery Bypass Clinical Trial
— TELE-PEACEOfficial title:
TELEsurveillance of Patients in PostopErative Bridge surgeryAge CoronairE, Pilot Study
Verified date | May 2023 |
Source | Assistance Publique - Hôpitaux de Paris |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
More than 20,000 patients benefit from coronary bypass surgery in France each year. Median discharge without complication is eight days postoperatively, whereas by day four after surgery, hospitalization is only necessary for medical supervision of the occurrence of complications (scar infection, atrial fibrillation, pericardial effusion), waiting for a downstream bed in cardiac rehabilitation. Some studies have shown the feasibility of a return home from day 4 after CABG in the United States and England under some conditions of selection and monitoring of patients. However, there is currently no validated telemonitoring tool for patients in early postoperative coronary bypass surgery. In this pilot study, during hospitalization for early postoperative coronary bypass surgery, a combination of connected devices for the measurement of physiological parameters and for clinical self-evaluation by the patient will be evaluated. The results of this project will be used as a basis for a future larger study in which an early home discharge can be proposed to patients.
Status | Completed |
Enrollment | 33 |
Est. completion date | December 31, 2022 |
Est. primary completion date | June 30, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: 1. Patients 18 years of age or older at baseline 2. Patient for whom isolated coronary bypass was performed 3. From the 4th day after the operation, epicardial electrodes removed since at least the day before inclusion day, normal blood pressure and heart rate, O2 saturation greater than 94% in ambient air, apyrexia, clean scar, not sign of congestive heart failure 4. From the 4th day after surgery, ECG of the day in sinus rhythm 5. From the 4th day after surgery, hemoglobin> 8g / dl, creatinine clearance> 30ml / min, during a blood sample of less than 24 hours 6. From the 4th day after the operation, no significant abnormalities during a chest X-ray less than 24 hours 7. From the 4th day after surgery, FEVG> 30%, dry pericardium or pericardial effusion = 1cm without compression during transthoracic echocardiography less than 24 hours Exclusion Criteria: - Patients at high risk of complications: - Insulinorequising diabetics, - Non-autonomous, - With a context unfavorable to the implementation of the intervention: patient speaking little or no French, patient without social coverage, patient unable to manage complex actions on connected tools. - Refusal to sign the consent. Protected persons (tutorship, safeguard of justice) |
Country | Name | City | State |
---|---|---|---|
France | Cimadevilla | Paris |
Lead Sponsor | Collaborator |
---|---|
Assistance Publique - Hôpitaux de Paris | GFI |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Blood pressure measured by connected armband | The Evolution of blood pressure will be measured daily by connected armband, from day 4 postoperatively to discharge from hospital. | day 12 postoperatively or discharge from hospital | |
Primary | Temperature measured by connected thermometer | The Evolution of Temperature will be measured daily by connected thermometer, from day 4 postoperatively to discharge from hospital. | day 12 postoperatively or discharge from hospital | |
Primary | Heartbeat measured by connected electrocardiogram | The heartbeat will be measured daily by connected electrocardiogram, from day 4 postoperatively to discharge from hospital. | day 12 postoperatively or discharge from hospital | |
Primary | scar appearance | The Evolution of scar appearance will be measured daily by photography, from day 4 postoperatively to discharge from hospital. | day 12 postoperatively or discharge from hospital | |
Primary | pain measured | The Evolution of pain will be measured daily by an electronic analog visual pain scale, from day 4 postoperatively to discharge from hospital. | day 12 postoperatively or discharge from hospital | |
Secondary | Connected armband measurements | Concordance between connected armband blood pressure measurements, and reference measurements performed by the health care team during hospitalization. | day 12 postoperatively or discharge from hospital | |
Secondary | Connected thermometer measurements. | Concordance between Temperature measured by connected thermometer and reference measurements performed by the health care team during hospitalization disorders, the investigators will evaluate (i) the concordance between the automatic interpretation of the connected ECG and the reading of the classical ECG on the one hand, (ii) the concordance between the automatic interpretation of the ECG connected and re-reading of this same route by a cardiologist. | day 12 postoperatively or discharge from hospital | |
Secondary | Connected electrocardiogram | Concordance between connected electrocardiogram heart rate and reference measurements performed by the health care team during hospitalization. Concerning rhythm disorders, the investigators will evaluate (i) the concordance between the automatic interpretation of the connected ECG and the reading of the classical ECG on the one hand, (ii) the concordance between the automatic interpretation of the ECG connected and re-reading of this same route by a cardiologist. | day 12 postoperatively or discharge from hospital | |
Secondary | photography of scar | Concordance between photography of scar appearance (flow, inflammation), and reference measurements performed by the health care team during hospitalization. | day 12 postoperatively or discharge from hospital | |
Secondary | analog visual pain scale | Concordance between connected an electronic analog visual pain scale and reference measurements performed by the health care team during hospitalization. | day 12 postoperatively or discharge from hospital | |
Secondary | Technical failures of connected objects. | Incidence of occurrence of technical failures of connected objects. | day 12 postoperatively or discharge from hospital | |
Secondary | alert algorithms for the diagnosis of postoperative complications | Sensitivity and specificity of alert algorithms for the diagnosis of postoperative complications (pericardial effusion, heart failure, infection, atrial fibrillation). | day 12 postoperatively or discharge from hospital | |
Secondary | Time between surgery and when the patient meets inclusion criteria | Time between surgery and when the patient meets the clinical, ECG, biological, radiographic and echocardiographic inclusion criteria | day 8 postoperatively | |
Secondary | self-measurements performed by the patient | Proportion of self-measurements performed by the patient using the connected objects among all self-measurements requested. | day 12 postoperatively or discharge from hospital | |
Secondary | items completed by the patient in the application | Proportion of items completed by the patient in the application among the total of items to be completed. | day 12 postoperatively or discharge from hospital | |
Secondary | Patient satisfaction | Patient satisfaction measure | 1 month | |
Secondary | Caregiver satisfaction | Caregiver satisfaction measure | day 12 postoperatively or discharge from hospital | |
Secondary | post-operative complications after discharge from hospital | Incidence of occurrence of post-operative complications after discharge from hospital (phone contact on D30). | 1 month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03235323 -
Efficacy of External CounterPulsation for Postoperative Coronary Artery Bypass Grafting Patients
|
N/A | |
Completed |
NCT05036044 -
Stroke and Carotid-Cerebral Vascular Disease After CABG
|
||
Recruiting |
NCT05010460 -
Study of Roxadustat for Reducing the Incidence of Acute Kidney Injury After Coronary Artery Bypass Grafting
|
Phase 2 | |
Completed |
NCT03622671 -
Fibrin Clot Properties and Blood Loss Following Coronary Artery By-pass Grafting
|
N/A | |
Completed |
NCT00400790 -
Organ Protection for Coronary Artery Bypass Graft (CABG): Propofol Versus Desflurane
|
N/A | |
Not yet recruiting |
NCT03275220 -
Assessment Of Right Ventricular Function In Patients Undergoing Coronary Artery Bypass Graft In Assiut University
|
N/A | |
Completed |
NCT01256372 -
An Trial of Two Dosing Regimens of AP214 for the Prevention of Kidney Injury in Patients Undergoing Cardiac Surgery
|
Phase 2 | |
Completed |
NCT00489827 -
Glutamate for Metabolic Intervention in Coronary Surgery
|
Phase 3 | |
Completed |
NCT04591119 -
Transversus Thoracis Muscle Plane Block for Postoperative Pain in Adult Cardiac Surgery
|
N/A | |
Active, not recruiting |
NCT03908593 -
Proton Pump Inhibitor Preventing Upper Gastrointestinal Injury In Patients On Dual Antiplatelet Therapy After CABG
|
Phase 4 | |
Recruiting |
NCT03774342 -
The Influence of Cognitive Decline on Quality of Life After Coronary Bypass
|
||
Enrolling by invitation |
NCT03999398 -
Short and Long-term Results of PCI in no Touch Vein-graft.
|
||
Recruiting |
NCT05414331 -
WithDRawal Impact Of Postoperative Beta-Blocker
|
N/A | |
Completed |
NCT02981680 -
Effect of Remote Ischemic Preconditioning on the Incidence of Acute Kidney Injury in Patients Undergoing Coronary Artery Bypass Graft Surgery
|
N/A | |
Completed |
NCT00600704 -
Impact of Fluid Restriction Policy in Reducing the Use of Red Cells in Cardiac Surgery
|
N/A | |
Completed |
NCT06013605 -
Effect of Walking Exercise on Functional Capacity and Productivity in Patients After Coronary Artery Bypass Graft
|
N/A | |
Active, not recruiting |
NCT02731794 -
On-pump Beating Coronary Artery Bypass Grafting by Ventricular Assist
|
Phase 4 | |
Completed |
NCT02722213 -
Mindfulness & Stress Management Study for Cardiac Patients
|
N/A | |
Completed |
NCT01285271 -
A Pre- and Post- Coronary Artery Bypass Graft Implantation Disposed Application of Xenon
|
Phase 3 | |
Completed |
NCT00823082 -
Use of Antithrombin in Cardiac Surgery With Cardiopulmonary Bypass
|
Phase 2 |